Antirheumatic Therapy: Actions and Outcomes
Author:   Richard O. Day ,  Daniel E. Furst ,  Piet L.C.M. van Riel ,  Barry Bresnihan
Publisher:   Birkhauser Verlag AG
Edition:   2005 ed.
ISBN:  

9783764365950


Pages:   343
Publication Date:   15 December 2004
Format:   Hardback
Availability:   Out of stock   Availability explained
The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available.

Our Price $498.96 Quantity:  
Add to Cart

Share |

Antirheumatic Therapy: Actions and Outcomes


Add your own review!

Overview

This book gives a comprehensive overview of disease-modifying antirheumatic drugs (DMARDs). The introductory general chapters deal with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field; the following specific chapters characterize each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicity, and monitoring. For each agent some background is given, recent developments and influence of the treatment on patients quality of life and long-term outcomes are presented.

Full Product Details

Author:   Richard O. Day ,  Daniel E. Furst ,  Piet L.C.M. van Riel ,  Barry Bresnihan
Publisher:   Birkhauser Verlag AG
Imprint:   Birkhauser Verlag AG
Edition:   2005 ed.
Dimensions:   Width: 16.80cm , Height: 2.10cm , Length: 24.00cm
Weight:   0.787kg
ISBN:  

9783764365950


ISBN 10:   3764365951
Pages:   343
Publication Date:   15 December 2004
Audience:   College/higher education ,  Professional and scholarly ,  Tertiary & Higher Education ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Out of stock   Availability explained
The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available.

Table of Contents

Medicinal chemistry of the disease modifying anti-rheumatic drugs.- Targeting DMARD therapy.- Pharmacoeconomic properties of disease-modifying antirheumatic drugs.- Future molecular targets.- Hydroxychloroquine.- Sulfasalazine.- Parenteral gold.- Azathioprine.- Methotrexate.- Leflunomide.- Cyclosporin.- Tetracyclines.- Systemic glucocorticoids in rheumatoid arthritis.- TNF-? inhibitors.- Anakinra in rheumatoid arthritis.- Combination therapy.- Hematopoietic stem cell transplantation for the treatment of severe autoimmune diseases.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
 Shopping cart
Mailing List

 

Sign up now